• Latest Posts

Scientists create first CRISPR-based drug candidate targeting the microbiome

Promising results from phase 3 prostate cancer study

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline 

Cabaletta Bio’s lupus drug cleared for trial

ADVERTISEMENT

Mezzion Pharma raises $40M for treatment option for heart surgery patients

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

Researchers explain how some lung tumors avoid immunotherapy

Alzamend pushing ahead with Alzheimer’s vaccine trial

Destiny Pharma gel reduces nasal staph in surgery patients  

Vaccitech announces positive topline data for chronic hepatitis study

ADVERTISEMENT